Peringkat dalam Saham
#35102
Imunon, Inc. is a biotechnology firm in the clinical development stage,... Imunon, Inc. is a biotechnology firm in the clinical development stage, dedicated to innovating and commercializing DNA-centric immunotherapies, vaccines, and targeted chemotherapy solutions. Its primary pipeline assets include GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a unique formulation of doxorubicin encapsulated in heat-activated liposomes, currently being assessed for a variety of cancer indications. Furthermore, the company is advancing two early-phase platform technologies aimed at developing nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA treatments. Established in 1982, Imunon, Inc. maintains its operational base in Lawrenceville, New Jersey.
Harga Saham
$1.96
Terakhir disinkronkan: 2022-09-20
Kapitalisasi Pasar
$4.46M
Perubahan (1 tahun)
0.00%
Perdagangan Imunon, Inc. (CLSN)
Harga CLSN dengan kapitalisasi pasar B
Kapitalisasi pasar dari Imunon, Inc.(CLSN)
Kapitalisasi Pasar: $4.46M
Per August 2026, Imunon, Inc. memiliki kapitalisasi pasar sebesar $4.46M. Ini menjadikan Imunon, Inc. sebagai perusahaan 35102nd paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Imunon, Inc. dari 2008 hingga 2026
CLSN dibandingkan dengan 5 teratas stocks paling populer
| Harga CLSN |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.452T
|
+122,315,667.42%
|
|
|
|
|
$4.490T
|
+100,736,067.78%
|
|
|
|
|
$4.162T
|
+93,385,879.57%
|
|
|
|
|
$3.676T
|
+82,480,743.03%
|
|
|
|
|
$2.833T
|
+63,560,829.91%
|
